Cargando…

Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: A study protocol

INTRODUCTION: The market for dietary supplements in the sports sector has been growing rapidly for several years, though there is still lacking evidence regarding their claimed benefits. One group is that of nitric oxide increasing supplements, so-called “NO-boosters,” which are claimed to improve t...

Descripción completa

Detalles Bibliográficos
Autores principales: Doll, Julian, Bürkle, Franziska, Neide, Arndt, Tsitlakidis, Stefanos, Bruckner, Thomas, Schmidmaier, Gerhard, Fischer, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544292/
https://www.ncbi.nlm.nih.gov/pubmed/33031270
http://dx.doi.org/10.1097/MD.0000000000022318
_version_ 1783591830812622848
author Doll, Julian
Bürkle, Franziska
Neide, Arndt
Tsitlakidis, Stefanos
Bruckner, Thomas
Schmidmaier, Gerhard
Fischer, Christian
author_facet Doll, Julian
Bürkle, Franziska
Neide, Arndt
Tsitlakidis, Stefanos
Bruckner, Thomas
Schmidmaier, Gerhard
Fischer, Christian
author_sort Doll, Julian
collection PubMed
description INTRODUCTION: The market for dietary supplements in the sports sector has been growing rapidly for several years, though there is still lacking evidence regarding their claimed benefits. One group is that of nitric oxide increasing supplements, so-called “NO-boosters,” which are claimed to improve the supply of oxygen and nutrients to the muscle by enhancing vasodilation. The aim of this study was to investigate 3 of these supplements in healthy male athletes for their muscle perfusion-enhancing potential using contrast-enhanced ultrasound (CEUS). METHODS: This placebo-controlled, double-blind, randomized cross-over trial will be carried out at the Center for Orthopedics, Trauma Surgery and Spinal Cord Injury of the University Hospital Heidelberg. Three commercial NO enhancing products including 300 mg of the specific green tea extract VASO6 and a combination of 8 g L-citrulline malate and 3 g L-arginine hydrochloride will be examined for their potential to increase muscular perfusion in 30-male athletes between 18 and 40 years and will be compared with a placebo. On each of the 3 appointments CEUS of the dominant biceps muscle will be performed at rest and after a standardized resistance training. Every athlete receives each of the 3 supplements once after a wash-out period of at least 1 week. Perfusion will be quantified via VueBox quantification software. The results of CEUS perfusion measurements will be compared intra- and interindividually and correlated with clinical parameters. DISCUSSION: The results of this study may help to establish CEUS as a suitable imaging modality for the evaluation of potentially vasodilatory drugs in the field of sports. Other supplements could also be evaluated in this way to verify the content of their advertising claims. TRIAL REGISTRATION: German Clinical Trials Register (DRKS), ID: DRKS00016972, registered on 25.03.2019.
format Online
Article
Text
id pubmed-7544292
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-75442922020-10-30 Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: A study protocol Doll, Julian Bürkle, Franziska Neide, Arndt Tsitlakidis, Stefanos Bruckner, Thomas Schmidmaier, Gerhard Fischer, Christian Medicine (Baltimore) 6800 INTRODUCTION: The market for dietary supplements in the sports sector has been growing rapidly for several years, though there is still lacking evidence regarding their claimed benefits. One group is that of nitric oxide increasing supplements, so-called “NO-boosters,” which are claimed to improve the supply of oxygen and nutrients to the muscle by enhancing vasodilation. The aim of this study was to investigate 3 of these supplements in healthy male athletes for their muscle perfusion-enhancing potential using contrast-enhanced ultrasound (CEUS). METHODS: This placebo-controlled, double-blind, randomized cross-over trial will be carried out at the Center for Orthopedics, Trauma Surgery and Spinal Cord Injury of the University Hospital Heidelberg. Three commercial NO enhancing products including 300 mg of the specific green tea extract VASO6 and a combination of 8 g L-citrulline malate and 3 g L-arginine hydrochloride will be examined for their potential to increase muscular perfusion in 30-male athletes between 18 and 40 years and will be compared with a placebo. On each of the 3 appointments CEUS of the dominant biceps muscle will be performed at rest and after a standardized resistance training. Every athlete receives each of the 3 supplements once after a wash-out period of at least 1 week. Perfusion will be quantified via VueBox quantification software. The results of CEUS perfusion measurements will be compared intra- and interindividually and correlated with clinical parameters. DISCUSSION: The results of this study may help to establish CEUS as a suitable imaging modality for the evaluation of potentially vasodilatory drugs in the field of sports. Other supplements could also be evaluated in this way to verify the content of their advertising claims. TRIAL REGISTRATION: German Clinical Trials Register (DRKS), ID: DRKS00016972, registered on 25.03.2019. Lippincott Williams & Wilkins 2020-10-09 /pmc/articles/PMC7544292/ /pubmed/33031270 http://dx.doi.org/10.1097/MD.0000000000022318 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 6800
Doll, Julian
Bürkle, Franziska
Neide, Arndt
Tsitlakidis, Stefanos
Bruckner, Thomas
Schmidmaier, Gerhard
Fischer, Christian
Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: A study protocol
title Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: A study protocol
title_full Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: A study protocol
title_fullStr Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: A study protocol
title_full_unstemmed Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: A study protocol
title_short Contrast-enhanced ultrasound for determining muscular perfusion after oral intake of L-citrulline, L-arginine, and galloylated epicatechines: A study protocol
title_sort contrast-enhanced ultrasound for determining muscular perfusion after oral intake of l-citrulline, l-arginine, and galloylated epicatechines: a study protocol
topic 6800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544292/
https://www.ncbi.nlm.nih.gov/pubmed/33031270
http://dx.doi.org/10.1097/MD.0000000000022318
work_keys_str_mv AT dolljulian contrastenhancedultrasoundfordeterminingmuscularperfusionafteroralintakeoflcitrullinelarginineandgalloylatedepicatechinesastudyprotocol
AT burklefranziska contrastenhancedultrasoundfordeterminingmuscularperfusionafteroralintakeoflcitrullinelarginineandgalloylatedepicatechinesastudyprotocol
AT neidearndt contrastenhancedultrasoundfordeterminingmuscularperfusionafteroralintakeoflcitrullinelarginineandgalloylatedepicatechinesastudyprotocol
AT tsitlakidisstefanos contrastenhancedultrasoundfordeterminingmuscularperfusionafteroralintakeoflcitrullinelarginineandgalloylatedepicatechinesastudyprotocol
AT brucknerthomas contrastenhancedultrasoundfordeterminingmuscularperfusionafteroralintakeoflcitrullinelarginineandgalloylatedepicatechinesastudyprotocol
AT schmidmaiergerhard contrastenhancedultrasoundfordeterminingmuscularperfusionafteroralintakeoflcitrullinelarginineandgalloylatedepicatechinesastudyprotocol
AT fischerchristian contrastenhancedultrasoundfordeterminingmuscularperfusionafteroralintakeoflcitrullinelarginineandgalloylatedepicatechinesastudyprotocol